(PDF) P1.09-04 Optimization of PD-L1 Testing Specimen Flow

P1.09-04 Optimization of PD-L1 Testing Specimen Flow in the Greater Hamilton, Ontario Region

Journal of Thoracic Oncology - United States

doi 10.1016/j.jtho.2018.08.780

Full Text

Abstract

Available in full text

Categories

Respiratory Medicine

Date

October 1, 2018

Authors

Publisher

Elsevier BV

Related search

P1.09-01 PD-L1 Testing on NSCLC Cytology Samples in a UK Teaching Hospital

Journal of Thoracic Oncology

Respiratory Medicine

English

PD-L1 Assessment for Targeted Therapy Testing in Cancer

Applied Immunohistochemistry and Molecular Morphology

Forensic Medicine

Medical Laboratory Technology

English

P1.09-05 Why Does PD-L1 (22C3) Expression Rate Show Difference Among Regional Hospitals?

Journal of Thoracic Oncology

Respiratory Medicine

English

The Challenges of Implementing a PD-L1 Proficiency Testing Program in Australia

Computer Networks

Developmental Neuroscience

English

Testing PD-1/PD-L1 Expression in Cancer Therapy: Pathologic Insights and Economic Sustainability

Archives of Pathology and Laboratory Medicine

Forensic Medicine

Medical Laboratory Technology

English

P1.09-06 the Incidence of PD-L1 in NSCLC and Its Correlation With Driver Mutations in Turkish Patients; A Single Center Experience

Journal of Thoracic Oncology

Respiratory Medicine

English

P3.09-04 Assessment of PD-L1 Expression in Cytology Samples: An Anlaysis of 263 Consecutive NSCLC Biopsies.

Journal of Thoracic Oncology

Respiratory Medicine

English

P1.09-03 Challenges in PD-L1 Immunoexpression in Liquid Based Cytology Samples of Advanced Stage Non-Small Cell Lung Carcinomas

Journal of Thoracic Oncology

Respiratory Medicine

English

7. PD-L1 in Triple Negative Breast Cancer – Optimal Testing for Therapeutic Efficacy

Forensic Medicine

English